Holen Sie sich die Stockscreener-App
308.13
1.86%
-5.84
Handel nachbörslich:
308.13
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Improving research efficiency with high-performance flow cytometry - News-Medical
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety - GlobeNewswire
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity - Yahoo Finance
Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid - GlobeNewswire
Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid Expansion in the Venous Blood Collection Market Through 2032 - Yahoo Finance
United States Microfluidics Devices Market Expands Rapidly - openPR.com
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays - MSN
Is Bio-Rad Laboratories, Inc. (NYSE:BIO) Potentially Undervalued? - 富途牛牛
Polymerase Chain Reaction (PCR) Market Rapid Growt 2025-2033: - openPR.com
Basic Statistics in Laboratory Quality Control - Labroots
Why (BIO) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
What is the fair value estimate for Bio Rad Laboratories Inc. (BUW) stock in 2025Market Sentiment Summary & High Conviction Buy Zone Picks - Newser
What insider purchases suggest about Bio Rad Laboratories Inc. Class stockEarnings Miss & Low Risk High Reward Ideas - Newser
How Bio Rad Laboratories Inc. (BUWA) stock performs in volatility spikesJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Why Bio Rad Laboratories Inc. (BUW) stock is upgraded to buyJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - Newser
Is Bio Rad Laboratories Inc. Class B stock a good hedge against inflationWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Why Bio Rad Laboratories Inc. (BUW) stock could break out in 2025Analyst Upgrade & Stock Market Timing Techniques - Newser
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSys - pharmiweb.com
Will Bio Rad Laboratories Inc. (BUWA) stock recover faster than industryTrade Entry Summary & Long-Term Safe Return Strategies - Newser
Will Bio Rad Laboratories Inc. (BUW) stock deliver compounding returnsGap Down & Weekly Watchlist for Hot Stocks - Newser
Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and MoreResearchAndMarkets.com - The AI Journal
Can Bio Rad Laboratories Inc. Class stock expand revenue streams2025 Year in Review & Weekly Top Gainers Alerts - Newser
How geopolitical risks impact Bio Rad Laboratories Inc. (BUWA) stockTrade Exit Report & Consistent Profit Trading Strategies - Newser
Why Bio Rad Laboratories Inc. stock is in analyst buy zoneEarnings Overview Summary & Low Risk High Reward Ideas - Newser
Will Bio Rad Laboratories Inc. (BUW) stock outperform energy sector in 2025Share Buyback & Free Weekly Watchlist of Top Performers - Newser
Why Bio Rad Laboratories Inc. (BUWA) stock is a must watch tickerEntry Point & Long-Term Capital Growth Strategies - Newser
Will Bio Rad Laboratories Inc. (BUW) stock recover faster than industry - Newser
Can Bio Rad Laboratories Inc. (BUWA) stock resist broad market declinesJuly 2025 Update & Weekly Stock Breakout Alerts - Newser
Circulating Biomarkers Market Projections 2025-2032: Key - openPR.com
Next Generation Sequencing Library Preparation Market - openPR.com
Hydroxyapatite Market Size, Scope 2031 by Key Companies- Zimmer - openPR.com
Fisher Asset Management LLC Sells 5,884 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Share Price Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Will Bio Rad Laboratories Inc. Class B stock announce special dividendNew Guidance & Verified Trade Idea Suggestions - Newser
What earnings margins imply for Bio Rad Laboratories Inc. Class B stockMarket Risk Report & Verified Technical Trade Signals - Newser
Bio-Rad Laboratories (NYSE: BIO) insider files to sell 776 shares under Rule 144 - Stock Titan
Bio-Rad Laboratories, Inc. $BIO Position Trimmed by Legal & General Group Plc - MarketBeat
Rhumbline Advisers Has $12.10 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Why analysts maintain buy rating on Bio Rad Laboratories Inc. (BUW) stockJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - Newser
Is Bio Rad Laboratories Inc. Class stock undervalued by metrics2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
Will Bio Rad Laboratories Inc. Class stock rise with strong economyWeekly Stock Analysis & Low Risk Profit Maximizing Plans - Newser
Capital Fund Management S.A. Makes New Investment in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Will Bio Rad Laboratories Inc. (BUW) stock benefit from infrastructure bill2025 Momentum Check & Stock Portfolio Risk Management - Newser
Will Bio Rad Laboratories Inc. stock return to pre crisis levelsTrade Entry Summary & Entry Point Strategy Guides - Newser
Published on: 2025-12-02 01:11:23 - Newser
Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile? - MSN
How Bio Rad Laboratories Inc. (BUWA) stock stacks up against competitors2025 Retail Activity & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-12-01 23:20:24 - Newser
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts - Yahoo! Finance Canada
Swiss National Bank Lowers Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Shares Bought by Franklin Resources Inc. - MarketBeat
Will Bio Rad Laboratories Inc. stock outperform growth indexesJuly 2025 Movers & Daily Volume Surge Trade Alerts - moha.gov.vn
0.52%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):